Clinical trial
DiSCERN Phase I - Objective Quality of Life Detection Validation
NCT04121793 is registered in ClinicalTrials.gov with Great Lakes NeuroTechnologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DiSCERN Phase I - Objective Quality of Life Detection Validation
- Lead sponsor
- Great Lakes NeuroTechnologies Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 20, 2019
- Completion date
- June 30, 2020
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.